Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use Of Pertuzumab And Trastuzumab Emtansine In Adult Patients With Her2-Positive Metastatic Or Locally Recurrent Unresectable Breast Cancer

NCT03025711 is registered in ClinicalTrials.gov with BELEN RUIZ-ANTORAN as lead sponsor.

NCT NCT03025711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03025711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use Of Pertuzumab And Trastuzumab Emtansine In Adult Patients With Her2-Positive Metastatic Or Locally Recurrent Unresectable Breast Cancer
Lead sponsor
BELEN RUIZ-ANTORAN
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
January 31, 2020
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms